Articles related to DEPRESSION

NeuroStar is the first FDA-approved transcranial magnetic stimulation (TMS) system developed to treat major depressive disorders. With the new FDA approval, this TMS system will allow physicians to better treat patients with obsessive compulsive disorder (OCD) without the need for additional hardware.

Cannabis use increases the likelihood that patients will develop several negative health conditions, such as insomnia, anxiety, psychosis, and depression. As such, cannabis use should be prescribed carefully by physicians.

A new case study that analyzed the correlation between the use of antidepressants and suicide concluded that all patients treated with antidepressants should receive careful monitoring for clinical worsening, suicidality, or unusual changes in behavior.

There’s nothing like the sun when it comes to essential vitamin D. When your patients don’t get enough of it, fatigue and a host of other symptoms may arise. Here are 10 to keep an eye on if you think there may be a deficiency of vitamin D in your patients.

This CME program from the Cleveland Clinic Journal of Medicine explores a patient with a history of major depressive disorder, progressively worsening altered mental status, intermittent blank staring, blurred vision, bilateral incoordination of the upper and lower extremities, difficulty following commands, and decreased verbal communication. Would you rule out stroke? Serotonin syndrome? Earn some credits while discovering the diagnosis.